TRETINOIN MICROSPHERE Drug Patent Profile
✉ Email this page to a colleague
When do Tretinoin Microsphere patents expire, and when can generic versions of Tretinoin Microsphere launch?
Tretinoin Microsphere is a drug marketed by Encube and is included in one NDA.
The generic ingredient in TRETINOIN MICROSPHERE is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tretinoin Microsphere
A generic version of TRETINOIN MICROSPHERE was approved as tretinoin by PADAGIS US on December 24th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRETINOIN MICROSPHERE?
- What are the global sales for TRETINOIN MICROSPHERE?
- What is Average Wholesale Price for TRETINOIN MICROSPHERE?
Summary for TRETINOIN MICROSPHERE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Clinical Trials: | 6 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRETINOIN MICROSPHERE |
DailyMed Link: | TRETINOIN MICROSPHERE at DailyMed |
![TRETINOIN MICROSPHERE drug patent expirations Drug patent expirations by year for TRETINOIN MICROSPHERE](/p/graph/s/t/TRETINOIN_MICROSPHERE-patent-expirations.png)
![Drug Prices for TRETINOIN MICROSPHERE](/p/graph/drug-price/TRETINOIN+MICROSPHERE.png)
Recent Clinical Trials for TRETINOIN MICROSPHERE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Taro Pharmaceuticals USA | Early Phase 1 |
Galderma Laboratories, L.P. | Phase 4 |
Spear Pharmaceuticals | Phase 3 |
Pharmacology for TRETINOIN MICROSPHERE
Drug Class | Retinoid |
US Patents and Regulatory Information for TRETINOIN MICROSPHERE
TRETINOIN MICROSPHERE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting TRETINOIN MICROSPHERE
COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Encube | TRETINOIN MICROSPHERE | tretinoin | GEL;TOPICAL | 215609-001 | Aug 22, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |